Raoul Herbrecht

发表

Vincent Liu, Edward C.C. Wong, David A. Jacobsohn, 2012 .

A European prospective invasive mould disease audit

Anne Sonet, Cornelia Lass-Flörl, Raoul Herbrecht, 2014 .

Factors associated with overall and attributable mortality in invasive aspergillosis.

Philippe Lutun, Bruno Lioure, Karin Bilger, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America.

Raoul Herbrecht, Thomas J Walsh, Kieren A Marr, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.

Pierre Morel, Raoul Herbrecht, Felix Reyes, 2002, The New England journal of medicine.

Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign.

Raoul Herbrecht, John E Bennett, R. Rubin, 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Discovery and identification of potential biomarkers in a prospective study of chronic lymphoid malignancies using SELDI-TOF-MS.

Alain Van Dorsselaer, Raoul Herbrecht, L. Miguet, 2006, Journal of proteome research.

Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.

Patricia Muñoz, Angela Restrepo, Raoul Herbrecht, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Saccharomyces cerevisiae fungemia: an adverse effect of Saccharomyces boulardii probiotic administration.

Raoul Herbrecht, R. Herbrecht, Y. Nivoix, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Caspofungin: the first representative of a new antifungal class.

Raoul Herbrecht, R. Herbrecht, V. Letscher-Bru, 2003, The Journal of antimicrobial chemotherapy.

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis.

Richard Sylvester, Raoul Herbrecht, John E Bennett, 2002, The New England journal of medicine.